GENE ONLINE|News &
EU Issues New Guidelines to Fortify Radiopharmaceutical Supply Chain Amid Rising Demand for Cancer Treatments
New guidelines from the European Union aim to strengthen the radiopharmaceutical supply chain, as the industry faces growing strain. These medicines, critical in treating diseases like cancer, are the focus of the new EU guidance. The impetus for these recommendations stems from increasing pressure on the complex network that produces and distributes radiopharmaceuticals. The new guidance seeks to address vulnerabilities within this supply chain.
Newsflash | Powered by GeneOnline AI
Date: April 15, 2025
Related posts:
Experts Urge Inclusion of Pets in Disease Surveillance Amid Rising H5N1 Cases in Cats
Global Generic Drug Market Projected to Reach $1.3 Trillion by 2027, Driven by Demand in Developing Nations
Generic Drug Makers Use Stability Testing in Freedom to Operate Analysis to Ensure Regulatory Compliance.
Police at Greater Risk of Brain Trauma and PTSD
LATEST
The Latest Talk in Cancer Immunotherapy: A Brief Overview of Developments & Current Players in the Exosome Space
2025-04-23
Unlocking the Gut Code: Japan’s Pharmaceutical Sector Explores the Future of Microbiome Therapeutics
2025-04-23
Advancing Pharmaceutical Regulatory Cooperation in Asia: The Vision and Challenges of GMP Inspection Reliance
2025-04-23
Cross-Border Trust and Transparency: The New Landscape of Bridging the Regulatory Review in the Asia-Pacific
2025-04-23
